CHRS — Coherus Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Coherus Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	417	192	118	126	172
Net Total Accounts Receivable
Net Total Receivables	123	110	261	122	18.4
Total Inventory
Prepaid Expenses
Total Current Assets	602	381	476	342	207
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16	14.4	11	7.36	4.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	679	481	630	449	258
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	165	139	332	283	140
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	582	618	823	581	197
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	97.7	-137	-193	-132	61
Total Liabilities & Shareholders' Equity	679	481	630	449	258
Total Common Shares Outstanding